|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Equipment, net | ||||||||||||||||||||
| Capitalized software, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Redeemable Preferred Stock and Stockholders' Deficit | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Liability related to the sale of future royalties | ||||||||||||||||||||
| Warrant Liability | ||||||||||||||||||||
| Liability related to the sale of future royalties | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable preferred stock | ||||||||||||||||||||
| Series A convertible preferred stock; $0.0001 par value; 200,000 shares authorized; liquidation preference of $0; 5,539 shares issued and outstanding as of June 30, 2026 and 3,296 shares issued and outstanding as of December 31, 2025 | ||||||||||||||||||||
| Stockholders' deficit | ||||||||||||||||||||
| Common stock; $0.0001 par value; 250,000,000 shares authorized; 47,227,259 shares issued and outstanding as of June 30, 2026 and 43,274,398 shares issued and outstanding as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities, redeemable preferred stock and stockholders' deficit | ||||||||||||||||||||
Loading...
